Cotreatment | mtDNA/nDNA Hybridization Ratio in WT Mice | mtDNA/nDNA Hybridization Ratio in MnSOD+/− Mice | ||||
---|---|---|---|---|---|---|
0 h | 2 h | 24 h | 0 h | 2 h | 24 h | |
% untreated WT mice | ||||||
None | 100 ± 4 | 64 ± 4# | 103 ± 5 | 101 ± 2 | 44 ± 4#,* | 67 ± 4#,* |
Tempol | 102 ± 7 | 97 ± 10† | 94 ± 7 | 98 ± 7 | 102 ± 11† | 72 ± 9#,*,† |
l-NAME | 99 ± 3 | 85 ± 5#,† | 111 ± 4 | 99 ± 3 | 78 ± 4#,*,† | 93 ± 2† |
1400W | 105 ± 11 | 99 ± 10† | 94 ± 9 | 106 ± 9 | 88 ± 8† | 103 ± 10† |
Uric acid | 99 ± 3 | 96 ± 3† | 97 ± 4 | 91 ± 4 | 76 ± 3#,*,† | 96 ± 3#,*,† |
↵# Different from untreated mice (0 h) of the same genotype receiving the same cotreatment, if any (P < 0.05, two-way ANOVA).
↵* Different from WT mice studied at the same treatment time (0, 2, or 24 h) and receiving the same cotreatment, if any (P < 0.05, two-way ANOVA).
↵† Different from mice of the same genotype studied at the same treatment time but without any cotreatment (P < 0.05, one-way ANOVA within the WT group or within the MnSOD+/− group).